| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President, Global A &M A | EVP, Global A &M Adherence +2 more
1 company
Seim Robin Gene is a Director at OMNICELL, INC.. Recent SEC Form 4 filings include 0 buys and 15 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 9, 2021 | OMCL Omnicell, Inc. | Director | Sell | 6,686 | $151.60 | $1,013,585.73 | -5.0% | +18.2% | -30.8% | |
| Jan 4, 2021 | OMCL Omnicell, Inc. | Director | Sell | 1,319 | $119.62 | $157,778.78 | -3.6% | - | - | |
| Mar 11, 2019 | OMCL Omnicell, Inc. | President, Global A &M A | Sale+OE | 28,800 | $83.70 | $2,410,528.32 | -16.0% | - | - | |
| Jun 4, 2018 | OMCL Omnicell, Inc. | President, Global A &M A | Sale+OE | 15,658 | $48.00 | $751,584.00 | -17.4% | - | - | |
| May 15, 2018 | OMCL Omnicell, Inc. | President, Global A &M A | Sale+OE | 13,286 | $46.48 | $617,523.98 | -15.2% | - | - | |
| Sep 15, 2017 | OMCL Omnicell, Inc. | EVP, Global A &M Adherence | Sale+OE | 9,780 | $48.97 | $478,965.72 | -17.5% | - | - | |
| Aug 15, 2017 | OMCL Omnicell, Inc. | EVP, Global A &M Adherence | Sale+OE | 15,109 | $50.86 | $768,482.99 | -13.2% | - | - | |
| Jul 6, 2016 | OMCL Omnicell, Inc. | EVP, Global A &M Adherence | Sell | 5,302 | $34.75 | $184,238.67 | -9.6% | - | - | |
| Jul 1, 2016 | OMCL Omnicell, Inc. | EVP, Global A &M Adherence | Sale+OE | 3,645 | $35.00 | $127,575.00 | -6.2% | - | - | |
| Apr 29, 2016 | OMCL Omnicell, Inc. | EVP, Global A &M Adherence | Sale+OE | 6,407 | $31.00 | $198,617.00 | -9.7% | - | - |